Drug Shortage Report for BREVIBLOC INJECTION 10MG/ML
Report ID | 126749 |
Drug Identification Number | 02188880 |
Brand name | BREVIBLOC INJECTION 10MG/ML |
Common or Proper name | BREVIBLOC INJECTION 10MG/ML |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | ESMOLOL HYDROCHLORIDE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 25 units/case |
ATC code | C07AB |
ATC description | BETA BLOCKING AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2020-10-20 |
Actual start date | 2020-10-20 |
Estimated end date | 2020-11-09 |
Actual end date | 2020-11-09 |
Shortage status | Resolved |
Updated date | 2020-11-10 |
Company comments | Baxter product BREVIBLOC Injection esmolol hydrochloride Solution, 10 mg/mL (2500 mg/250 mL bags) (DIN: 02309238) is available as an alternative if it aligns with clinical practice. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2020-11-10 | English | Compare |
v5 | 2020-11-09 | French | Compare |
v4 | 2020-11-09 | English | Compare |
v3 | 2020-10-21 | English | Compare |
v2 | 2020-10-20 | French | Compare |
v1 | 2020-10-20 | English | Compare |
Showing 1 to 6 of 6